# ğŸ¯ MY OWNERSHIP PLAN - CLARIFIED & VERIFIED

**Date:** January 28, 2025  
**Status:** âœ… CLARIFIED - Ready to Proceed  
**Based On:** AGENT_OWNERSHIP_REGISTRY.md + ORCHESTRATION_IMPLEMENTATION_STATUS.md + JR Agent D Review

---

## âœ… JR AGENT D REVIEW (Trial Matching)

### What I Verified

**Implementation:** `api/services/trials/trial_matching_agent.py` (~650 lines)

**âœ… CORRECT:**
- Manager P4 Compliance: `alpha=0.7, beta=0.3` âœ… (matches `MECHANISM_FIT_ALPHA = 0.7, MECHANISM_FIT_BETA = 0.3`)
- Manager P4 Thresholds: `min_eligibility=0.60, min_mechanism_fit=0.50` âœ… (matches constants)
- Manager P3 Compliance: `use_gemini_tag=True` âœ… (prefers Gemini tags, runtime fallback)
- Orchestrator Integration: âœ… Wired in `orchestrator.py:601-633`
- Data Models: âœ… TrialMatch, TrialMatchingResult, TrialMoA, EligibilityCriteria
- Error Handling: âœ… Proper try/except and logging

**âš ï¸ MINOR NOTES:**
- Uses dict-based patient profiles (not dataclass PatientProfile from MDC spec) - **Acceptable** (orchestrator converts)
- Eligibility scoring is simplified (`_estimate_eligibility_score`) - **Acceptable** (can enhance later)
- No QueryGenerator class (uses AutonomousTrialAgent directly) - **Acceptable** (wiring existing services)

**Conclusion:** âœ… **JR Agent D's implementation is CORRECT and COMPLETE**

---

## ğŸ“Š MY OWNERSHIP - CLARIFIED

### Current State (Verified)

| Component | Location | Status | In Orchestration? | My Role? |
|-----------|----------|--------|-------------------|----------|
| **S/P/E Framework** | `api/services/efficacy_orchestrator/` | âœ… Built | âŒ Not wired to MOAT | âŒ Not mine (JR Agent C) |
| **Gene Essentiality Endpoint** | `/api/insights/predict_gene_essentiality` | âœ… Built | âŒ Not an agent | âœ… Can enhance |
| **Synthetic Lethality Frontend** | `oncology-frontend/src/components/SyntheticLethality/` | âœ… Built | âŒ Not in orchestration | âœ… Can integrate |
| **Synthetic Lethality Backend** | `/api/guidance/synthetic_lethality` | âœ… Built | âŒ Not in orchestration | âœ… Can integrate |
| **AI Explanations Frontend** | `AIExplanationPanel.jsx` | âœ… Built | âŒ Not in orchestration | âœ… Can integrate |
| **Module 14 MDC** | `14_SYNTHETIC_LETHALITY_ESSENTIALITY_AGENT.mdc` | âœ… Created | âŒ Removed from index | âœ… **I OWN THIS** |

### What's Assigned (Ownership Registry)

| Module | Owner | Status | My Role? |
|--------|-------|--------|----------|
| **04_DRUG_EFFICACY** | **JR Agent C** | â³ PENDING | âŒ Not mine - contribute fixes only |
| **14_SYNTHETIC_LETHALITY** | **NOT IN REGISTRY** | âœ… MDC exists | âœ… **I SHOULD OWN THIS** |

---

## ğŸ¯ DECISION: MODULE 14 (Separate Module)

### Rationale

**Why Separate Module 14 (Not Integrated into Module 04):**

1. **Different Purpose:**
   - Module 04: Rank drugs by S/P/E (general efficacy)
   - Module 14: Identify synthetic lethality opportunities (specific strategy)

2. **Different Inputs:**
   - Module 04: Needs S/P/E scores, pathway burden, evidence
   - Module 14: Needs gene essentiality, broken pathways, dependency mapping

3. **Different Outputs:**
   - Module 04: Ranked drug list with S/P/E breakdown
   - Module 14: Synthetic lethality result with essentiality scores, broken pathways, essential backups, SL drug recommendations

4. **Bidirectional Relationship:**
   - Module 14 can enhance Module 04 (essentiality scores boost S component)
   - Module 04 can inform Module 14 (drug rankings inform SL recommendations)
   - But they're **complementary, not the same**

5. **Already Has Complete MDC:**
   - I created `14_SYNTHETIC_LETHALITY_ESSENTIALITY_AGENT.mdc` (1,725 lines)
   - Full implementation spec with all components
   - Frontend already built
   - Benchmark validated (50% drug match, 100% Evo2)

**Conclusion:** âœ… **Module 14 should be separate, and I should own it**

---

## âœ… WHAT I WILL PROCEED WITH

### Step 1: Add Module 14 to Ownership Registry âœ…

**Update:** `.cursor/MOAT/AGENT_OWNERSHIP_REGISTRY.md`

Add:
```markdown
### `AGENT_14_SL_ESSENTIALITY` - Synthetic Lethality & Essentiality Agent

**Owner:** AI Agent (Synthetic Lethality Specialist)  
**Status:** â³ PENDING  
**Priority:** ğŸŸ¡ HIGH

#### Responsibilities
- Score gene essentiality using Evo2
- Map broken pathways from mutations
- Identify essential backup pathways (synthetic lethality)
- Recommend drugs targeting essential backups
- Generate AI explanations (3 audiences)

#### Files to Create
```
api/services/synthetic_lethality/
â”œâ”€â”€ __init__.py
â”œâ”€â”€ sl_agent.py                    # Main agent
â”œâ”€â”€ essentiality_scorer.py         # Evo2 integration
â”œâ”€â”€ pathway_mapper.py              # Pathway disruption
â”œâ”€â”€ dependency_identifier.py       # Essential backups
â”œâ”€â”€ drug_recommender.py            # SL drug recommendations
â”œâ”€â”€ explanation_generator.py       # AI explanations
â”œâ”€â”€ constants.py                   # Pathways, genes, drugs
â”œâ”€â”€ models.py                      # Data models
â””â”€â”€ tests/
```

#### Acceptance Criteria
- [ ] Gene essentiality scored with Evo2
- [ ] Broken pathways identified
- [ ] Essential backups determined
- [ ] Drugs recommended targeting backups
- [ ] AI explanations generated (3 audiences)
- [ ] Integrated with orchestrator
- [ ] Benchmark validated (50% drug match, 100% Evo2)
```

### Step 2: Add Module 14 to Master Index âœ…

**Update:** `.cursor/MOAT/orchestration/00_MASTER_INDEX.mdc`

Add to module directory:
```markdown
| 14 | [Synthetic Lethality & Essentiality](./14_SYNTHETIC_LETHALITY_ESSENTIALITY_AGENT.mdc) | SLEssentialityAgent | ğŸŸ¡ HIGH | 01, 02, 04 | â³ PENDING |
```

Add to execution order (Phase 3):
```markdown
PHASE 3: ADVANCED INTELLIGENCE (Week 3-4)
â”œâ”€â”€ 04_DRUG_EFFICACY_AGENT.mdc # S/P/E framework
â”œâ”€â”€ 14_SYNTHETIC_LETHALITY_ESSENTIALITY_AGENT.mdc # âœ… MDC Complete
â”œâ”€â”€ 05_TRIAL_MATCHING_AGENT.mdc # Mechanism vector âœ… COMPLETE
â””â”€â”€ 07_CARE_PLAN_AGENT.mdc     # Unified output
```

Add to cross-module dependencies:
```yaml
14_SYNTHETIC_LETHALITY_ESSENTIALITY:
  depends_on: [01, 02, 04]
  provides: SyntheticLethalityResult, GeneEssentialityScore, AIExplanation
  consumers: [04, 05, 07]
  status: â³ PENDING  # MDC complete, implementation pending
```

### Step 3: Document Module 04 Fixes (For JR Agent C) âœ…

**Create:** `.cursor/MOAT/MODULE_04_CRITICAL_FIXES.md`

**Content:**
- Pathway normalization bug fix (range 0-0.005, not 1e-6 to 1e-4)
- Tier computation parameter fix (use raw `s_path`, not normalized `path_pct`)
- Tier threshold adjustment (0.001 for new pathway range)
- Sporadic gates capping fix (only apply when tumor context provided)
- Code examples with before/after
- Test cases to validate fixes

**Purpose:** Give JR Agent C the fixes they need when building Module 04

### Step 4: Build Module 14 Implementation âœ…

**Files to Create:**
```
api/services/synthetic_lethality/
â”œâ”€â”€ __init__.py
â”œâ”€â”€ sl_agent.py                    # Main orchestrating agent
â”œâ”€â”€ essentiality_scorer.py         # Evo2 integration
â”œâ”€â”€ pathway_mapper.py              # Pathway disruption mapping
â”œâ”€â”€ dependency_identifier.py       # Essential backup identification
â”œâ”€â”€ drug_recommender.py            # Drug recommendation engine
â”œâ”€â”€ explanation_generator.py       # AI explanation generation
â”œâ”€â”€ constants.py                   # Pathways, genes, thresholds
â”œâ”€â”€ models.py                      # Data models
â””â”€â”€ tests/
    â”œâ”€â”€ test_essentiality.py
    â”œâ”€â”€ test_pathways.py
    â”œâ”€â”€ test_recommendations.py
    â””â”€â”€ test_integration.py
```

**Implementation Approach:**
- Follow the MDC spec exactly (1,725 lines of detailed code)
- Wire to orchestrator (similar to how JR Agent D did it)
- Integrate with existing endpoints (`/api/evo/score_variant_multi`, `/api/llm/explain`)
- Reuse frontend components (already built)

### Step 5: Wire to Orchestrator âœ…

**Update:** `api/services/orchestrator/orchestrator.py`

Add method:
```python
async def _run_synthetic_lethality_agent(self, state: PatientState) -> Dict:
    """Run the synthetic lethality & essentiality agent."""
    from ..synthetic_lethality import SyntheticLethalityAgent
    
    # Build request from state
    request = SyntheticLethalityRequest(
        disease=state.disease,
        mutations=state.mutations,
        options={'include_explanations': True}
    )
    
    # Run agent
    agent = SyntheticLethalityAgent()
    result = await agent.analyze(request)
    
    # Store in state
    state.synthetic_lethality_result = result
    
    return asdict(result)
```

Add to orchestrator flow (after drug efficacy, before trial matching)

---

## ğŸ“‹ IMPLEMENTATION CHECKLIST

### Phase 1: Registry & Index Updates (Day 1)
- [ ] Add Module 14 to `AGENT_OWNERSHIP_REGISTRY.md`
- [ ] Add Module 14 to `00_MASTER_INDEX.mdc`
- [ ] Update cross-module dependencies
- [ ] Create `MODULE_04_CRITICAL_FIXES.md` for JR Agent C

### Phase 2: Core Backend (Days 2-3)
- [ ] Create `api/services/synthetic_lethality/` directory
- [ ] Implement `essentiality_scorer.py` with Evo2 integration
- [ ] Implement `pathway_mapper.py` with pathway definitions
- [ ] Implement `dependency_identifier.py` with SL relationships
- [ ] Implement `drug_recommender.py` with drug catalog
- [ ] Create `constants.py` with pathways, genes, drugs

### Phase 3: AI Integration (Day 4)
- [ ] Implement `explanation_generator.py` with LLM integration
- [ ] Create prompts for 3 audiences (clinician/patient/researcher)
- [ ] Test explanation quality

### Phase 4: Agent & Orchestrator (Day 5)
- [ ] Implement `sl_agent.py` (main orchestrating agent)
- [ ] Wire to orchestrator
- [ ] Create API endpoint `/api/agents/synthetic_lethality`
- [ ] Add error handling and logging

### Phase 5: Testing & Validation (Day 6)
- [ ] Write unit tests (>80% coverage)
- [ ] Run benchmark validation (pilot 10 cases)
- [ ] Integration test with orchestrator
- [ ] Verify 100% Evo2 usage

---

## ğŸ”— INTEGRATION POINTS

### Consumes From

| Module | Data | Purpose |
|--------|------|---------|
| **01_DATA_EXTRACTION** | `PatientProfile`, `mutations` | Input mutations |
| **02_BIOMARKER** | `BiomarkerProfile`, `hrd` | HRD status for PARP eligibility |
| **04_DRUG_EFFICACY** | `DrugEfficacyResult` | Can enhance S component with essentiality |

### Provides To

| Module | Data | Purpose |
|--------|------|---------|
| **04_DRUG_EFFICACY** | `essentiality_scores` | Boost S component scoring |
| **05_TRIAL_MATCHING** | `broken_pathways`, `mechanism` | Filter trials by mechanism |
| **07_CARE_PLAN** | `recommended_drugs`, `explanation` | Include in care plan |

### Data Flow

```
[01_DATA_EXTRACTION] â†’ mutations
         â†“
[02_BIOMARKER] â†’ biomarker_profile
         â†“
[14_SYNTHETIC_LETHALITY_ESSENTIALITY] â†’ SyntheticLethalityResult
         â†“
    â”Œâ”€â”€â”€â”€â”´â”€â”€â”€â”€â”
    â†“         â†“
[04_DRUG]  [05_TRIAL] â†’ [07_CARE_PLAN]
```

---

## âœ… SUMMARY

**What I'm Clear On:**
- âœ… Module 14 should be separate (not integrated into Module 04)
- âœ… I should own Module 14 (I created the MDC, have the expertise)
- âœ… JR Agent C owns Module 04 (I'll contribute fixes only)
- âœ… JR Agent D's implementation is correct (good reference)

**What I'll Do:**
1. âœ… Add Module 14 to ownership registry
2. âœ… Add Module 14 to master index
3. âœ… Document Module 04 fixes for JR Agent C
4. âœ… Build Module 14 implementation (following MDC spec)
5. âœ… Wire to orchestrator
6. âœ… Test and validate

**Timeline:** 5-6 days for full implementation

---

**Status:** âœ… CLARIFIED - Ready to Proceed  
**Next Step:** Update ownership registry and master index, then start implementation

